Trials / Sponsors / GELLC (Grupo Español de Leucemia Linfocítica Crónica)
GELLC (Grupo Español de Leucemia Linfocítica Crónica)
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Gro Richter Syndrome | Phase 2 | 2024-05-15 |